nach oben

Supportive Care in Cancer

Erschienen in:

01.02.2005 | Original Article

Anticipatory nausea and vomiting

verfasst von: Matti S. Aapro, Alexander Molassiotis, Ian Olver

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2005

Einloggen, um Zugang zu erhalten

Abstract

Anticipatory nausea and vomiting (ANV) is not only a learned response but can occur without prior exposure to chemotherapy depending on patient emotional distress and expectations. The best method to avoid development or reinforcement of ANV is to avoid both vomiting and nausea from the first exposure to chemotherapy. If ANV develops, benzodiazepines have been documented to help in adult patients, and several psychological techniques are also of help, including systematic desensitization. The evidence on which these conclusions are based is reviewed in this article.

Aapro MS, Kirchner V, Terrey JP (1994) The incidence of anticipatory nausea and vomiting after repeat cycle chemotherapy: the effect of granisetron. Br J Cancer 69:957–960PubMed

Andrykowski MA, Redd WH, Hatfield AK (1985) Development of anticipatory nausea: a prospective analysis. J Consult Clin Psychol 53:447–454CrossRefPubMed

Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC) (1998) Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Ann Oncol 9:811–819CrossRefPubMed

Burish TG, Shartner CD, Lyles JN (1981) Effectiveness of multiple muscle-site EMG biofeedback and relaxation training in reducing the aversiveness of cancer chemotherapy. Biofeedback Self Regul 6:523–535PubMed

Carey MP, Burish TG (1988) Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion. Psychol Bull 104:307–325CrossRefPubMed

Collins KB, Thomas DJ (2004) Acupuncture and acupressure for the management of chemotherapy-induced nausea and vomiting. J Am Acad Nurse Pract 16:76–80

Davey VA, Biederman GB (1998) Conditioned antisickness: indirect evidence from rats and direct evidence from ferrets that conditioning alleviates drug-induced nausea and emesis. J Exp Psychol Anim Behav Process 24:483–491CrossRefPubMed

Fernandez-Marcos A, Martin M, Sanchez JJ, Rodriguez-Lescure A, Casado A, Lopez Martin JA, Diaz-Rubio E (1996) Acute and anticipatory emesis in breast cancer patients. Support Care Cancer 4:370–377PubMed

Fetting JH, Sheidler VR, Stefanek ME, et al (1987) Clonidine for anticipatory nausea and vomiting: a pilot study examining dose-toxicity relationships and potential for further study. Cancer Treat Rep 71:409–410PubMed

10.

Gulhas N, Turkoz A, Durmus M, Togal T, Gedik E, Ersoy MO (2003) Oral clonidine premedication does not reduce postoperative vomiting in children undergoing strabismus surgery. Acta Anaesthesiol Scand 47:90–93CrossRefPubMed

11.

Hickok JT, Roscoe JA, Morrow GR (2001) The role of patients’ expectations in the development of anticipatory nausea related to chemotherapy for cancer. J Pain Symptom Manage 22:843–850CrossRefPubMed

12.

Hursti T, Fredrikson M, et al (1992) Association between personality characteristics and the prevalence and extinction of conditioned nausea after chemotherapy. J Psychosoc Oncol 10:59–77

13.

Kim Y, Morrow GR (2003) Changes in family relationships affect the development of chemotherapy-related nausea symptoms. Support Care Cancer 11:171–177PubMed

14.

Lett BT (1983) Pavlovian drug-sickness pairings result in the conditioning of an antisickness response. Behav Neurosci 97:779–784CrossRefPubMed

15.

Malik IA, Khan WA, Qazilbash M, Ata E, Butt A, Khan MA (1995) Clinical efficacy of lorazepam in prophylaxis of anticipatory, acute, and delayed nausea and vomiting induced by high doses of cisplatin. A prospective randomized trial. Am J Clin Oncol 18:170–175PubMed

16.

Marchioro G, Azzarello G, Viviani F, Barbato F, Pavanetto M, Rosetti F, Pappagallo GL, Vinante O (2000) Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapy. Oncology 59:100–104CrossRefPubMed

17.

Matteson, S, Roscoe J, Hickok J, Morrow GR (2002) The role of behavioral conditioning in the development of nausea. Am J Obstet Gynecol 185 [5 Suppl]:S239–S243

18.

Mayer DJ (2000) Acupuncture: an evidence-based review of the clinical literature. Annu Rev Med 51:49–63CrossRefPubMed

19.

Molassiotis A (1999) Further evaluation of a scale to screen for risk of emotional difficulties in bone marrow transplant recipients. J Adv Nurs 29:922–927CrossRefPubMed

20.

Molassiotis A, Yung HP, Yam BM, Chan FY, Mok TS (2002) The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial. Support Care Cancer 10:237–246CrossRefPubMed

21.

Montgomery GH, Bovbjerg DH (2003) Expectations of chemotherapy-related nausea: emotional and experiential predictors. Ann Behav Med 25:48–54CrossRefPubMed

22.

Morrow GR (1984) Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment. J Clin Oncol 2:1170–1176PubMed

23.

Morrow GR, Rosenthal SN (1996) Models, mechanisms and management of anticipatory nausea and emesis. Oncology 53 [Suppl 1]:4–7

24.

Morrow GR, Lindke J, Black PM (1991) Predicting development of anticipatory emesis in cancer patients: prospective examination of eight characteristics. J Pain Symptom Manage 6:215–223CrossRefPubMed

25.

Morrow GR, Roscoe JA, Kirshner JJ, Hynes HE, Rosenbluth RJ (1998) Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics. Support Care Cancer 6:244–247CrossRefPubMed

26.

Mundy EA, DuHamel KN, Montgomery GH (2003) The efficacy of behavioral interventions for cancer treatment-related side effects. Semin Clin Neuropsychiatr 8:253–275

27.

Oddby-Muhrbeck E, Eksborg S, Bergendahl HT, Muhrbeck O, Lonnqvist PA (2002) Effects of clonidine on postoperative nausea and vomiting in breast cancer surgery. Anesthesiology 96:1109–1114CrossRefPubMed

28.

Parker LA, Kemp SW (2001) Tetrahydrocannabinol (THC) interferes with conditioned retching in Suncus murinus: an animal model of anticipatory nausea and vomiting (ANV). Neuroreport 12:749–7 51CrossRefPubMed

29.

Raynaud G (1995) Current status of the activity of 5-HT3 receptor antagonists in animal pharmacology. Ann Pharm Fr 53:19–23PubMed

30.

Razavi D, Delvaux N, Farvacques C, et al (1993) Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. J Clin Oncol 11:1384–1390PubMed

31.

Redd WH, Andresen GV, Minagawa RY (1982) Hypnotic control of anticipatory emesis in patients receiving cancer chemotherapy. J Consult Clin Psychol 50:14–19CrossRefPubMed

32.

Redd WH, Montgomery GH, DuHamel KN (2001) Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst 93:810–823CrossRefPubMed

33.

Stockhorst U, Klosterhalfen S, Klosterhalfen W, Winkelmann M, Steingrueber HJ (1993) Anticipatory nausea in cancer patients receiving chemotherapy: classical conditioning etiology and therapeutical implications. Integr Physiol Behav Sci 28:177–181PubMed

34.

Stockhorst U, Wiener JA, Klosterhalfen S, Klosterhalfen W, Aul C, Steingruber HJ (1998) Effects of overshadowing on conditioned nausea in cancer patients: an experimental study. Physiol Behav 64:743–753CrossRefPubMed

35.

Stockhorst U, Spennes-Saleh S, Korholz D, Gobel U, Schneider ME, Steingruber HJ, Klosterhalfen S (2000) Anticipatory symptoms and anticipatory immune responses in pediatric cancer patients receiving chemotherapy: features of a classically conditioned response? Brain Behav Immun 14:198–218CrossRefPubMed

36.

Vasterling J, Jenkins RA, Tope DM, Burish TG (1993) Cognitive distraction and relaxation training for the control of side effects due to cancer chemotherapy. J Behav Med 16:65–80PubMed

37.

Watson M, Meyer L, Thomson A, Osofsky S (1998) Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy. Eur J Cancer 34:831–837CrossRefPubMed

38.

Weddington WW, Miller NJ, Sweet DL (1984) Anticipatory nausea and vomiting associated with cancer chemotherapy. J Psychosom Res 28:73–77CrossRefPubMed

39.

Wilcox PM, Fetting JH, Nettesheim KM, Abeloff MD (1982) Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma. Cancer Treat Rep 66:1601–1604PubMed

40.

Yugin L (1989) Treating patients with nervous vomiting in the dental office by point-stimulating therapy. Spec Care Dentist 9:27–28PubMed

Titel: Anticipatory nausea and vomiting
verfasst von: Matti S. Aapro
Alexander Molassiotis
Ian Olver
Publikationsdatum: 01.02.2005
Verlag: Springer-Verlag
Erschienen in: Supportive Care in Cancer / Ausgabe 2/2005
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-004-0745-8

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Anticipatory nausea and vomiting

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2005

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an update

Antiemetics in children receiving chemotherapy

Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy

Forthcoming Meetings February 2005

Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement

Emesis induced by low or minimal emetic risk chemotherapy

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie